Application 213239
- Type
- ANDA
- Sponsor
- HIKMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DEFERIPRONE | DEFERIPRONE | TABLET;ORAL | 500MG | No | No |
| 002 | DEFERIPRONE | DEFERIPRONE | TABLET;ORAL | 1GM | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0054-0576 | Deferiprone | Deferiprone | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0054-0576 | Deferiprone | Deferiprone | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0054-0576 | Deferiprone | Deferiprone | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0054-0576 | Deferiprone | Deferiprone | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0054-0711 | Deferiprone | Deferiprone | Hikma Pharmaceuticals USA Inc. | ANDA | Current |